title: Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
abstract: BACKGROUND
  Patients with end-stage renal disease are at high risk for cardiovascular morbidity and mortality. The aims of the present study were to describe the prevalence of peripheral arterial disease (PAD) and its effects on prognosis and health-related quality of life (HRQOL) in an international cohort of patients on hemodialysis.
  
  
  RESULTS
  Data from the Dialysis Outcomes and Practice Patterns Study (DOPPS), a prospective, international, observational study of hemodialysis patients (n=29,873), were analyzed. Associations between baseline clinical variables and PAD were evaluated by logistic regression analysis. Cox regression models were used to test the association between PAD and risk for all-cause mortality, cardiac mortality, and hospitalization. PAD was diagnosed in 7411 patients (25.3%) with significant geographic variation. Traditional cardiovascular risk factors including age, male sex, diabetes, hypertension, and smoking were identified, together with the duration of hemodialysis, as significant correlates of PAD. Diagnosis of PAD was associated with increased all-cause mortality (hazard ratio [HR]=1.36; P<0.0001), cardiac mortality (HR=1.43; P<0.0001), all-cause hospitalization (HR=1.19; P<0.0001), and hospitalization for a major adverse cardiovascular event (HR=2.05; P<0.0001). HRQOL questionnaires revealed physical health scores that were significantly lower in PAD compared with non-PAD patients (P<0.0001).
  
  
  CONCLUSIONS
  PAD is common in hemodialysis patients and is associated with increased risk of cardiovascular mortality, morbidity, and hospitalization and reduced HRQOL.
authors.affiliation: Division of Cardiovascular Medicine, 473 W 12th Ave, Ohio State University, Columbus, OH 43202, USA. Sanjay.Rajagopalan@osumc.edu
authors.forename: Sanjay
authors.initials: S
authors.lastname: Rajagopalan
authors.forename: Santo
authors.initials: S
authors.lastname: Dellegrottaglie
authors.forename: Anna L
authors.initials: AL
authors.lastname: Furniss
authors.forename: Brenda W
authors.initials: BW
authors.lastname: Gillespie
authors.forename: Sudtida
authors.initials: S
authors.lastname: Satayathum
authors.forename: Norbert
authors.initials: N
authors.lastname: Lameire
authors.forename: Akira
authors.initials: A
authors.lastname: Saito
authors.forename: Takashi
authors.initials: T
authors.lastname: Akiba
authors.forename: Michel
authors.initials: M
authors.lastname: Jadoul
authors.forename: Nancy
authors.initials: N
authors.lastname: Ginsberg
authors.forename: Marcia
authors.initials: M
authors.lastname: Keen
authors.forename: Friedrich K
authors.initials: FK
authors.lastname: Port
authors.forename: Debabrata
authors.initials: D
authors.lastname: Mukherjee
authors.forename: Rajiv
authors.initials: R
authors.lastname: Saran
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000150:complications / Q000453:epidemiology; D005260:Female; D006760:Hospitalization; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology*; D015995:Prevalence; D011379:Prognosis; D011788:Quality of Life; D006435:Renal Dialysis; D016019:Survival Analysis